Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (34)
Coronavirus disease 2019 (COVID-19) (7)
COVID-19 pandemic (7)
Gestational diabetes mellitus (GDM) (6)
Human immunodeficiency virus (HIV) (5)
Adolescent girls and young women (AGYW) (3)
SDG-03: Good health and well-being (3)
Biomarkers (2)
Diabetes (2)
Diabetes mellitus (2)
Low- and middle-income countries (LMICs) (2)
National Health Insurance (NHI) (2)
Non-communicable diseases (NCDs) (2)
Nucleic acid amplification testing (NAAT) (2)
Obesity (2)
Patients (2)
Pregnancy (2)
Rheumatoid arthritis (RA) (2)
Screening (2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2)
Type 2 diabetes mellitus (T2DM) (2)
Universal health coverage (UHC) (2)
Women (2)
Anemia (1)
Antenatal clinics (1)
Anti-CEP-1 (1)
Anti-citrullinated peptide (anti-CCP) (1)
Anti-citrullinated peptide antibodies (ACPAs) (1)
Anti-cyclic citrullinated peptide antibodies (ACPA) (1)
Anti-MCV (1)
Anti-Sa (1)
Aplastic anemia (AA) (1)
Audit (1)
Autoantibodies (1)
Autoantibody (1)
Awareness (1)
Biomarker (1)
Black person (1)
Black population (1)
Bone marrow disorder (1)
Brazil (1)
Calmodulin-binding transcription activator 1 (CAMTA1) (1)
Cancer (1)
Cardiovascular (1)
Cardiovascular disease (CVD) (1)
Cervical cancer (1)
Challenges (1)
Circumcision (1)
Clinic (1)
Condom use (1)
Cyclic citrullinated peptide antibody (1)
Diabetes knowledge (1)
Diabetes management self‐efficacy (1)
Diabetes-in-pregnancy (1)
Diagnosis (1)
Dietary behaviors (1)
Dietary self-care (1)
Disease severity (1)
DNA methylation (1)
Enzyme-linked immunosorbent assay (ELISA) (1)
Epidemiology (1)
Expression (1)
Fibrinolytic therapy (1)
Field performance (1)
Fluorescence analysis (1)
GAD65 (1)
Genetic predisposition (1)
Girls (1)
Global DNA methylation (1)
Health behavior (1)
Health status (1)
Hemoglobinuria (1)
High risk population (1)
HIV counseling and testing (HCT) (1)
Hospitalised cases (1)
Hypercholesterolaemia (1)
Hypogonadism (1)
IA-2 (1)
Immunoglobulin A (1)
Immunoglobulin G antibody (1)